EV/EBITDA
-1.47
+0.04+2.65%
10 min ago
Summary
- As of February 7, 2025, NKTR EV/EBITDA is -1.47, with a rise of +0.04 (+2.65%) during the most recent trading day.
- Over the past year, NKTR EV/EBITDA has dropped by -0.58 (-65.17%).
- NKTR EV/EBITDA is now -100.49% below its all-time high of 297.90.
Performance
NKTR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NKTR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | -2.8% | -4.5% |
| 1 m1 month | +34.1% | -34.2% | -45.9% |
| 3 m3 months | +36.4% | -36.5% | -48.4% |
| 6 m6 months | +26.9% | -31.3% | -41.1% |
| ytdytd | +21.0% | -21.0% | -30.2% |
| 1 y1 year | -65.2% | -6.7% | -4.1% |
| 5 y5 years | +87.0% | -95.3% | -97.0% |
NKTR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.23 | +34.1% | |
| 3 m | 3-month | -1.47 | at high | -2.48 | +40.7% |
| 6 m | 6-month | -1.47 | at high | -2.55 | +42.4% |
| 1 y | 1-year | -0.85 | -72.9% | -2.82 | +47.9% |
| 3 y | 3-year | -0.41 | -258.5% | -4.79 | +69.3% |
| 5 y | 5-year | -0.41 | -258.5% | -12.26 | +88.0% |
| alltime | all time | 297.90 | -100.5% | -2023 | +99.9% |
Nektar Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.47(-21.0%) |
| 2024 | -1.86(+132.5%) |
| 2023 | -0.80(-44.8%) |
| 2022 | -1.45(-74.5%) |
| 2021 | -5.68(-25.9%) |
| 2020 | -7.67(-29.2%) |
| 2019 | -10.83(-238.5%) |
| 2018 | 7.82(-103.2%) |
| 2017 | -241.88(+1014.7%) |
| 2016 | -21.70(-74.6%) |
| 2015 | -85.48(-89.1%) |
| 2014 | -785.11(+5689.9%) |
| 2013 | -13.56(+73.4%) |
| 2012 | -7.82(-1.5%) |
| 2011 | -7.94(-94.8%) |
| 2010 | -153.10(+1000.6%) |
| Date | Value |
|---|---|
| 2009 | -13.91(-105.9%) |
| 2008 | 233.84(-289.3%) |
| 2007 | -123.55(+781.2%) |
| 2006 | -14.02(+28.5%) |
| 2005 | -10.91(-68.1%) |
| 2004 | -34.18(+49.3%) |
| 2003 | -22.90(+148.9%) |
| 2002 | -9.20(-40.8%) |
| 2001 | -15.53(-61.5%) |
| 2000 | -40.36(+51.6%) |
| 1999 | -26.62(+8.0%) |
| 1998 | -24.64(-14.4%) |
| 1997 | -28.80(+107.8%) |
| 1996 | -13.86(+27.5%) |
| 1995 | -10.87(-13.4%) |
| 1994 | -12.55 |
FAQ
- What is Nektar Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Nektar Therapeutics?
- What is NKTR EV/EBITDA year-to-date change?
- What is Nektar Therapeutics EV/EBITDA year-on-year change?
What is Nektar Therapeutics EV/EBITDA?
The current EV/EBITDA of NKTR is -1.47
What is the all time high EV/EBITDA for Nektar Therapeutics?
Nektar Therapeutics all-time high EV/EBITDA is 297.90
What is NKTR EV/EBITDA year-to-date change?
Nektar Therapeutics EV/EBITDA has changed by +0.39 (+20.97%) since the beginning of the year
What is Nektar Therapeutics EV/EBITDA year-on-year change?
Over the past year, NKTR EV/EBITDA has changed by -0.58 (-65.17%)